NCT00005813View on ClinicalTrials.gov

Bispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 1997

Primary Completion Date

January 31, 2003

Study Completion Date

January 31, 2003

Conditions
Brain and Central Nervous System Tumors
Interventions
BIOLOGICAL

bispecific antibody MDX447

BIOLOGICAL

lymphokine-activated killer cells

PROCEDURE

conventional surgery

Trial Locations (1)

03756-0002

Dartmouth-Hitchcock Medical Center, Lebanon

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Dartmouth-Hitchcock Medical Center

OTHER